Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Kidney Disease Market?

The market size for kidney disease has seen a robust growth in the past few years. It is projected to expand from $107.29 billion in 2024 to $114.39 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.6%. The historic growth is due to several factors such as increasing chronic health issues, old age population, hereditary susceptibility, advancements in medical research and education, and environmental influences.

The market for kidney ailments is predicted to observe robust expansion in the coming years, reaching a size of $148.77 billion by 2029, with a compound annual growth rate of 6.8%. The anticipated growth over the forecast period can be linked to the management of worldwide infectious diseases, accuracy medicine strategies, the worsening diabetes and obesity crisis, amendments in healthcare policies, and heightened awareness and screening. Key trends throughout this forecast period encompass the use of telemedicine in kidney healthcare, an emphasis on preventive nephrology, an uptick in home-based dialysis, the advancement of regenerative therapies, along with dietary changes and nutrition.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Drivers Are Accelerating Expansion Of The Kidney Disease Market?

The escalating prevalence of kidney-related ailments is anticipated to boost the expansion of the kidney disease market in the future. Kidney diseases encompass a range of conditions that impair the kidneys’ functionality and structure. Medications for kidney disorders serve to decrease blood pressure in patients and minimize protein loss, thereby decelerating kidney damage, controlling symptoms, and averting complications. For example, as revealed by Kidney Research UK in June 2023, a charity organization in the UK specializing in research and advocacy to enhance the comprehension, prevention, and cure of kidney diseases, approximately 7.19 million individuals in the UK were diagnosed with chronic kidney disease in 2023. This equates to over 10% of the UK population, with projections estimating a rise to 7.61 million people by 2033. Consequently, the rising prevalence of kidney diseases is fuelling the growth of the kidney disease market.

What Are The Key Segment Trends Observed In The Kidney Disease Market?

The kidney diseasemarket covered in this report is segmented –

1) By Treatment: Medication; Dialysis; Surgery; Other Treatments

2) By Indication: Acute Kidney Injury; Chronic Kidney Disease; End-Stage Renal Disease; Other Indication

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Medication: Antihypertensives; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Vitamin D Analogs; Immunosuppressants

2) By Dialysis: Hemodialysis; Peritoneal Dialysis

3) By Surgery: Kidney Transplant; Nephrectomy; Renal Artery Bypass; Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications; Renal Replacement Therapy; Palliative Care

Which Long-Term Trends Will Play A Crucial Role In The Kidney Disease Market?

The emergence of AI-based tools is a prominent trend in the kidney disease market. Firms in this sector are welcoming new technologies to enhance patient results and maintain market dominance. For example, in November 2022, Carenostics, a US healthcare startup that specializes in AI solutions, introduced its first product to analyze electronic health record (EHR) data for early detection of chronic kidney disease (CKD). By easily integrating AI-empowered clinical decision support models into healthcare providers’ electronic health record (EHR) systems, Carenostics enables medical practitioners to accurately identify patients at high risk for chronic diseases, thus allowing them to take early actions to improve patient health outcomes.

Who Are The Major Stakeholders Operating In The Kidney Disease Market?

Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

What Regional Factors Are Accelerating Growth In The Kidney Disease Market?

North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Browse Through More Reports Similar to the Global Kidney Disease Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model